Why Clinicians Overtest: Development of a Thematic Framework
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
BMJ Open Is Committed to Open Peer Review. As Part of This Commitment We Make the Peer Review History of Every Article We Publish Publicly Available
BMJ Open: first published as 10.1136/bmjopen-2017-018448 on 27 December 2017. Downloaded from BMJ Open is committed to open peer review. As part of this commitment we make the peer review history of every article we publish publicly available. When an article is published we post the peer reviewers’ comments and the authors’ responses online. We also post the versions of the paper that were used during peer review. These are the versions that the peer review comments apply to. The versions of the paper that follow are the versions that were submitted during the peer review process. They are not the versions of record or the final published versions. They should not be cited or distributed as the published version of this manuscript. BMJ Open is an open access journal and the full, final, typeset and author-corrected version of record of the manuscript is available on our site with no access controls, subscription charges or pay- per-view fees (http://bmjopen.bmj.com). If you have any questions on BMJ Open’s open peer review process please email [email protected] http://bmjopen.bmj.com/ on September 25, 2021 by guest. Protected copyright. BMJ Open: first published as 10.1136/bmjopen-2017-018448 on 27 December 2017. Downloaded from BMJ Open Overdiagnosis across medical disciplines: a systematic review ForJournal: peerBMJ Open review only Manuscript ID bmjopen-2017-018448 Article Type: Research Date Submitted by the Author: 29-Jun-2017 Complete List of Authors: Jenniskens, Kevin; University Medical Center, Utrecht , Julius Center -
20–22 September 2016 BARCELONA
20–22 September 2016 BARCELONA PREVENTING OVERDIAGNOSIS • 1 WORKSHOP ABSTRACTS Preventing Overdiagnosis 2016 Conference Hosts Notice of photography and filming Preventing Overdiagnosis 2016 is being visually documented. By attending you acknowledge that you have been informed that you may be caught on camera during this event. Images taken will be treated as the property of Preventing Overdiagnosis and may be used in the future for promotional purposes. These images may be used without limitation by any organisation approved by the PODC Committee and edited prior to publication as seen fit for purpose. Images will be available on the internet accessible to internet users throughout the world including countries that may have less extensive data protection than partnering countries. All films and images will be securely stored on University of Oxford servers. Please make yourself known at registration if you wish to remain off camera. 2 • PREVENTING OVERDIAGNOSIS HOLA I BENVINGUTS! HELLO AND WELCOME! to the 4th international conference on Preventing Overdiagnosis We are delighted to welcome everyone to the conference here in Barcelona, and a warm thank you for coming. This year we have delegates attending from 30 countries, across all continents on earth. Overdiagnosis and overtreatment are challenges to all health systems around the world and this conference is a truly international collaborative event to address the important challenges facing all of us. Most of the conference will take place in English, but each day there will also be parallel sessions in Spanish. Together we will work to better understand the causes and consequences of overdiagnosis, and discuss a range of interventions to move forward with preventing it. -
Arizona Pain and Addiction Curriculum Faculty Guide
THE ARIZONA PAIN AND ADDICTION CURRICULUM FACULTY GUIDE UNDERGRADUATE HEALTH PROFESSIONAL EDITION 1 THE ARIZONA PAIN AND ADDICTION CURRICULUM FACULTY GUIDE | azhealth.gov/curriculum September 1, 2018 Dear Teaching Faculty: It is our pleasure to offer this Faculty Guide as a supplement to The Arizona Pain and Addiction Curriculum. Whether your program is educating future physicians, nurses, physician-assistants, dentists, naturopathic doctors or podiatrists – this Faculty Guide can be used to enhance the statewide vision of redefining pain and addiction. The essence of the curriculum rests with its ten Core Components – this Faculty Guide provides a further level of detail under each Component and Objective. As colleagues in health care, we understand that this material represents a significant change from the way we were taught about pain and addiction – or the way we were taught about medicine at all. This curriculum moves from a micro- to a macro- perspective, stressing whole-person care and the societal impact of pain and addiction. It reflects the interrelated nature of pain and addiction – two areas that have been traditionally siloed. It specifically calls for clinicians to be able to critically analyze material, their own practices, and their own biases. The approach to pain and addiction is advancing rapidly. The material in this Faculty Guide is aggressively up-to-date and evidence-based, yet remains in line with the National Pain Strategy, the Institute of Medicine and modern educational theories. As our understanding of pain and addiction changes, so too will this document. We are proud to have worked with programs’ leadership to develop this curriculum and are now excited to work with you to bring it to Arizona learners. -
2020 Generated On: 09/25/2020, 9:54:14 AM
Pepper_Annual_Boston_2019-2020 Generated on: 09/25/2020, 9:54:14 AM BOSTON PEPPER CENTER Claude D. Pepper Older Americans Independence Center Principal Investigator Shalender Bhasin, M.D. Program Administrator Molly Lukas [email protected] I. CENTER DESCRIPTION The Boston OAIC is unique in its thematic focus on Function Promoting Therapies (FPTs) and its positioning across the entire spectrum of translational science from mechanism elucidation, preclinical proof-of-concept studies, biomarker validation, epidemiologic investigation to randomized trials of FPTs. The Boston OAIC integrates 19 NIH-funded studies of function promoting therapies, 3 Research Education Component projects, 3 pilot projects, and 3 developmental projects into an interdisciplinary program that is supported by a Leadership and Administrative Core, a Research Education Component (REC), a Pilot and Exploratory Studies Core (PESC), and 3 resource cores (Function Assessment Core, Preclinical Discovery Core, Biostatistical and Data Analysis Core). Our REC and PESC candidates include several rising stars in Geriatrics and Gerontology, including 3 Beeson and K grant awardees. The REC will recruit the most promising stars from a vast reservoir of talent at Harvard, Tufts and BU, and train them through a didactic education and mentored research program. Integration will be achieved by the PROMOTE Program that includes a research concierge service, research meetings, annual retreats, a website and a newsletter. The Boston OAIC is well integrated with the the Harvard Geriatrics and Gerontology research community and programs, including its T32 training grant, Harvard Clinical Translational Science Institute, the Roybal Center, The New England Geriatrics Research Clinical Education Center, and the Glenn Foundation Center for Biology of Aging. -
BOOKTIVISM: the Power of Words
BOOKTIVISM: The Power of Words Book•ti•vi•sm(noun). 1. The mobilization of groups of concerned citizens produced by reading books offering powerful analyses of social or political issues. 2. A call to action based on the sharing of knowledge through books. 3. Books + activism = “booktivism.” 4. A term first used at the SellingSickness, 2013: People Before Profits conference in Washington, DC, see www.sellingsickness.com. Read. Discuss. Be thoughtful. Be committed. Here are some more suggestions to get you started: 1) Set up a reading group on disease-mongering among interested friends and colleagues. If you do The books included in BOOKTIVISM celebrate recent contributions to the broad topic of disease- not already have a group of interested readers, post a notice in your workplace, library, community mongering, especially as they examine the growing prevalence and consequences of overtreatment, center, apartment building, etc. Once you have a group, decide where to meet. Book clubs can overscreening, overmarketing, and overdiagnosis (see Lynn Payer’s 1992 classic, Disease-Mongers: How meet anywhere – at homes, in dorms, in pubs, in coffeehouses, at libraries, even online! Decide on Doctors, Drug Companies, and Insurers Are Making You Feel Sick, for an introduction to timing and format. Will you meet monthly/bimonthly? You’ll need time to prepare for the sessions, disease-mongering). but not so much time that you lose touch. Circulate the reading guide. It is usually best if one person leads each discussion, to have some questions at the ready and get things rolling. Although the challenge to disease-mongering is not unprecedented (the women’s health movement of the 1970s was another key historical moment), these books represent an impressive groundswell OR, maybe you’d like to of amazing, powerful, brilliant, and often deeply unsettling investigations by physicians, health scientists, 2) Set up a lecture/discussion group. -
Opioid Prescribing and Pain Management
Opioid Prescribing and Pain Management: Prescription Monitoring Program Overview and the Management of Acute Low Back Pain Conflict of Interest Disclosure and Funding Support Content Creation: CADTH Disclosures CADTH is an independent, not-for-profit organization funded by Canada’s federal, provincial, and territorial governments, with the exception of Quebec CADTH receives application fees for three programs: • CADTH Common Drug Review (CDR) • CADTH pan-Canadian Oncology Drug Review (pCODR) • CADTH Scientific Advice Relationships with commercial interests: None CADTH Opioid Prescribing and Acute Low Back Pain Module Collaborators Special acknowledgement and appreciation to the following organizations who supported the development of this slide deck: • New Brunswick Department of Health • New Brunswick Medical Society o Choosing Wisely New Brunswick CADTH Opioid Prescribing and Acute Low Back Pain Module Learning Objectives • Describe the risks associated with opioid use (including overdose, duration of therapy, and drug combinations). • Review the objectives of the prescription monitoring program (PMP) and how it can support decision-making at the point of care. • Examine the appropriate management of acute low back pain in the primary care setting. • Identify strategies for communicating the risks versus benefits of opioid therapy with patients. CADTH Opioid Prescribing and Acute Low Back Pain Module “The roots of what we now call the opioid crisis can be traced back many years to the promotion of opioid prescribing as low-risk, non-addictive, -
An Overview on High Health Care Costs in the US, Overdiagnosis, and Health Care Value
An Overview on High Health Care Costs in the US, Overdiagnosis, and Health Care Value Michael Tjahjadi, M.D. James Stallworth, M.D. Disclosures Neither Dr. Tjahjadi nor Dr. Stallworth has any financial incentives or relationships to disclose. The Healthcare System of the US We may have heard the phrases: Our healthcare system is broken Our spending in healthcare is unsustainable The US spends 2.5 times as much on health care as peer nations Yet some US outcomes trail peer nations Highest infant mortality rate Highest obesity rate US worst among high income countries when measured by specific population health outcomes Fairbrother et al, Pediatrics, June 2015 Ice-Breaker Question Is it too conflictual to ask clinicians to be cost-conscious and at the same time keep the welfare of the patient foremost in their minds? Yes No It depends Illustrative Case #1 15 year old AA male with SS trait presents with a 20 pound weight loss over 3 months despite an “ok” appetite. No change in bowel habits, no fever. He denies sexual activity and drug use, no history of blood transfusions and no other symptoms. He denies being depressed. On PE, he is quite thin with decreased subcutaneous tissue. His VS are stable but a HR of 110. He has no thrush, lymphadenopathy or HSM. He is Tanner 3. His exam is otherwise non revealing. From a health care value perspective, would you order an HIV? Illustrative Case #2 In June, a 22 mo previously healthy child presents with a 2 day history of diarrhea, 1 day of which is now bloody. -
Ten Things Physicians and Patients Should Question 3 1 2
The American College of Obstetricians and Gynecologists Ten Things Physicians and Patients Should Question Don’t schedule elective, non-medically indicated inductions of labor or Cesarean deliveries before 39 weeks 0 days gestational age. 1 Delivery prior to 39 weeks 0 days has been shown to be associated with an increased risk of learning disabilities and a potential increase in morbidity and mortality. There are clear medical indications for delivery prior to 39 weeks 0 days based on maternal and/or fetal conditions. A mature fetal lung test, in the absence of appropriate clinical criteria, is not an indication for delivery. Due to recently-published evidence related to induction of labor between 39 and 41 weeks gestation, the ACOG has withdrawn this 2 recommendation. Don’t perform routine annual cervical cytology screening (Pap tests) in women 30–65 years of age. 3 In average risk women, annual cervical cytology screening has been shown to offer no advantage over screening performed at 3-year intervals. However, a well-woman visit should occur annually for patients with their health care practitioner to discuss concerns and problems, and have appropriate screening with consideration of a pelvic examination. Don’t treat patients who have mild dysplasia of less than two years in duration. 4 Mild dysplasia (Cervical Intraepithelial Neoplasia [CIN 1]) is associated with the presence of the human papillomavirus (HPV), which does not require treatment in average risk women. Most women with CIN 1 on biopsy have a transient HPV infection that will usually clear in less than 12 months and, therefore, does not require treatment. -
Patient & Public Engagement in Choosing Wisely
PATIENT & PUBLIC ENGAGEMENT IN CHOOSING WISELY TOOLKIT | VERSION 1.0 Editors Anna Kurdina Karen Born Wendy Levinson Contributors Marco Bobbio Stephanie Callan Angela Coulter Moriah Ellen Amy Ma Robyn Lindner Paul Myres Ramai Santhirapala Todd Sikorski Choosing Wisely Canada receives support from The Commonwealth Fund, Bertelsmann Stiftung and Korea University to coordinate Choosing Wisely International. For more information, please contact [email protected] 2 CONTENTS BACKGROUND 4 Executive Summary 4 About Choosing Wisely International 7 Patient and Public Engagement 7 Framework 7 PARTNER 8 Case 1.1 - US: Partnership with Consumer Reports and 70 Other Organizations 9 Case 1.2 - Norway: Partnership with the Norwegian Patient Association 10 Case 1.3 - Canada: Patient Advisor Roles 11 Case 1.4 - Japan: Engagement Strategies with the Public nd Media 12 Case 1.5 - Italy: Partnerships with Altroconsumo and Partecipasalute 13 Case 1.6 - Australia: Consumer Stakeholder Roundtables 14 ENGAGE 15 Case 2.1 - New Zealand: Consumer Commentary Sessions 15 Case 2.2 - Canada: Canadian Rheumatology Association List 18 Case 2.3 - Israel: Recommendations from the Association of Family Physicians 19 Case 2.4 - UK: Specialty Societies Involving Patients 20 Case 2.5 - US: Tools to Engage Patients in QI Initiatives 21 Case 2.6 - Wales: “What matters to you/me” Day 22 Case 2.7 - Australia: Consumer Working Group 23 Case 2.8 - US: Community Conversations About Overuse 25 INFORM 26 Case 3.1 - Canada and New Zealand: Survey Data on Patient Attitudes -
Integrated Healthcare Association Align. Measure. Perform. (AMP) Programs
Integrated Healthcare Association Align. Measure. Perform. (AMP) Programs Measurement Year 2019 Manual Released September 1, 2019 No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording or any information storage and retrieval system, without the written permission of NCQA and IHA, except for the purposes of reporting quality data for the AMP programs or for internal quality improvement activities. © 2019 by the National Committee for Quality Assurance and Integrated Healthcare Association, all rights reserved. Table of Contents Table of Contents AMP Programs Overview Background .................................................................................................................................................... 1 AMP Commercial HMO Measurement and Reporting .................................................................................. 1 AMP Medicare Advantage Measurement and Reporting .............................................................................. 1 AMP Commercial ACO Measurement and Reporting ................................................................................... 2 AMP Medi-Cal Managed Care Measurement and Reporting ........................................................................ 2 Key Organizations Involved in Data Collection, Aggregation and Reporting ................................................ 3 Participation and Use of Results .................................................................................................................. -
Psychiatry.Pdf
Psychiatry Thirteen Things Physicians and Patients Should Question by Canadian Academy of Child and Adolescent Psychiatry Canadian Academy of Geriatric Psychiatry Canadian Psychiatric Association Last updated: June 2017 Don’t use atypical antipsychotics as a first-line intervention for insomnia in children and 1 youth. Recent research confirms a dramatic increase in the use of atypical antipsychotics with subsequent side-effects including obesity, which is already a major health issue. It is prudent to pursue nonpharmacological measures first, such as behavioural modifications and ensuring good sleep hygiene (such as eliminating daytime napping and shutting off electronics an hour before bedtime). If these interventions are not successful, then consider short-term use of melatonin. 2 Don’t use SSRIs as the first-line intervention for mild to moderately depressed teens. Evidence clearly indicates that antidepressant medication is less effective in children and adolescents up to the age of 17 years and first-line treatment for this group should include cognitive behavioural therapy or interpersonal psychotherapy. Attention should always be focused on children’s and teens’ environmental safety and adequate parental support to avoid missing cases of neglect or abuse. Following this, a first-line intervention should be psychoeducation on the importance of regular sleep, diet and exercise to ensure healthy, age-appropriate developmental support. 3 Don’t use atypical antipsychotics as a first-line intervention for Attention Deficit Hyperactivity Disorder (ADHD) with disruptive behaviour disorders. Treatment of ADHD should include adequate education of patients and their families, behavioural interventions, psychological treatments and educational accommodations first. If this approach is not sufficient, stimulant medication and a behavioural analysis to ensure appropriate support from the parent and classroom is indicated. -
Benzodiazepine Use Among Older Adults
Commentary For reprint orders, please contact: [email protected] Benzodiazepine use among older adults Aarti Gupta1 , Gargi Bhattacharya2 , Kripa Balaram3 , Deena Tampi4 & Rajesh R Tampi*,5,6 1Department of Psychiatry, Yale School of Medicine, New Haven, CT 06511, USA 2Department of Electrical and Computer Engineering, Purdue University, Indiana 47906, USA 3Department of Psychiatry, MetroHealth, Case Western Reserve University School of Medicine, Cleveland, OH 44109, USA 4Co-Founder and Managing Principal, Behavioral Health Advisory Group, Princeton, NJ 08542, USA 5Department of Psychiatry & Behavioral Sciences, Cleveland Clinic Akron General, Akron, OH 44307, USA 6Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH 44195, USA *Author for correspondence: Tel.: +1 203 809 5223; [email protected] “the use of benzodiazepines is increasing among older adults and they form the largest group of users for these drugs. These agents are effective in treating some clinical symptoms, but their use is fraught with serious side effects and addiction potential among older adults.” First draft submitted: 26 October 2020; Accepted for publication: 29 October 2020; Published online: 11 November 2020 Keywords: adverse effects • benzodiazepines • cognitive decline • elderly • falls • older adults Benzodiazepines are one of the most commonly prescribed psychotropic drugs in the developed world. Recent data from the 2015 to 2016 National Survey on Drug Use and Health show 30.6 million adults reported benzodiazepine use in the past year. The highest use of benzodiazepines of all age groups was reported by respondents aged 50–65 years at 14.3%, followed closely by the ≥65 years age group at 12.9% [1].